Login

Dedicare - ABGSC Investor Days 8 mars 2022 - Krister Widstrom, CEO, Dedicare AB (publ) 00:00:00

Share On Facebook Share On Twitter

Dedicare - ABGSC Investor Days 8 mars 2022

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:00:00
Jianyu Yang Chairman of the Board and Chief Executive Officer, Concord Medical Services Holdings Ltd
00:10:00
Exploration Potential in Newfoundland's Gold Rush: Exploits Discovery Overview
00:10:00
Concerns Over Federal Reserve Credibility Amid Inflation Strategy | Scott Sperling, CO-CEO, Thomas H. Lee Partners .
00:10:00
Transforming California's Landscape: A Vision for Sustainable Development and Growth part-1 | Emile Haddad , CEO,Five Point Holdings LLC.
00:10:00
Perion Network (PERI) CEO Tal Jacobson discusses digital advertising strategies with Nicole Petallides.
00:10:00
leading seed rounds for visionary B2B SaaS startups in the fastest growing, most promising venture capital|William Leonard,Investor,Valor Ventures
00:10:00
The Impact of Emotions and Cognitive Biases on Investment Decisions
00:10:00
Alisa Wood Discusses KKR's Private Market Investment Strategy on Bloomberg Markets | Alisa Wood - Client and Partner Group at KKR & Co Inc
00:00:00
Neil Campbell, CEO, Inspiration Healthcare Group
00:10:00
KNect365 Life Sciences about the company she co-founded as the latest spinout of Cold Spring Harbor Laboratory|Maria Luisa Pineda , CEO OF ENVISAGENICS, INC
00:10:00
conversations and now we are sharing them with you every month|Ari Newman,Partner, The Fund Rockies,The Fund
00:10:00
ActiveOps IPO: CEO Richard Jeffery on the Business Model and Market Potential | Richard Jeffery, CEO, ActiveOps Plc.

© 2017 - Neuhu+